GB201115095D0 - Method for detecting nucleosomes containing nucleotides - Google Patents

Method for detecting nucleosomes containing nucleotides

Info

Publication number
GB201115095D0
GB201115095D0 GBGB1115095.0A GB201115095A GB201115095D0 GB 201115095 D0 GB201115095 D0 GB 201115095D0 GB 201115095 A GB201115095 A GB 201115095A GB 201115095 D0 GB201115095 D0 GB 201115095D0
Authority
GB
United Kingdom
Prior art keywords
containing nucleotides
nucleosomes containing
detecting nucleosomes
detecting
nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1115095.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Singapore Volition Pte Ltd
Original Assignee
Singapore Volition Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Singapore Volition Pte Ltd filed Critical Singapore Volition Pte Ltd
Priority to GBGB1115095.0A priority Critical patent/GB201115095D0/en
Publication of GB201115095D0 publication Critical patent/GB201115095D0/en
Priority to HUE12756549A priority patent/HUE043386T2/hu
Priority to CA2845993A priority patent/CA2845993C/en
Priority to TR2019/04386T priority patent/TR201904386T4/tr
Priority to SG10201601153RA priority patent/SG10201601153RA/en
Priority to PT12756549T priority patent/PT2751568T/pt
Priority to CN201280053555.1A priority patent/CN104067124B/zh
Priority to MX2014002443A priority patent/MX364410B/es
Priority to EP12756549.7A priority patent/EP2751568B1/en
Priority to HRP20190533TT priority patent/HRP20190533T1/hr
Priority to RU2017126701A priority patent/RU2687483C2/ru
Priority to HK15100175.0A priority patent/HK1199760B/en
Priority to SG11201400270PA priority patent/SG11201400270PA/en
Priority to RU2014112350/15A priority patent/RU2014112350A/ru
Priority to JP2014527737A priority patent/JP6322845B2/ja
Priority to KR1020147008108A priority patent/KR102074528B1/ko
Priority to PL12756549T priority patent/PL2751568T3/pl
Priority to ES12756549T priority patent/ES2717659T3/es
Priority to AU2012300641A priority patent/AU2012300641B2/en
Priority to PCT/GB2012/052128 priority patent/WO2013030577A1/en
Priority to BR112014005087-2A priority patent/BR112014005087B1/pt
Priority to EP18212025.3A priority patent/EP3483608B1/en
Priority to US14/239,783 priority patent/US10900064B2/en
Priority to DK12756549.7T priority patent/DK2751568T3/en
Priority to ZA2014/01295A priority patent/ZA201401295B/en
Priority to US16/875,856 priority patent/US20200347435A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
GBGB1115095.0A 2011-09-01 2011-09-01 Method for detecting nucleosomes containing nucleotides Ceased GB201115095D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GBGB1115095.0A GB201115095D0 (en) 2011-09-01 2011-09-01 Method for detecting nucleosomes containing nucleotides
DK12756549.7T DK2751568T3 (en) 2011-09-01 2012-08-31 METHOD FOR DETECTING NUCLEOSOMES CONTAINING NUCLEOTIDES
SG11201400270PA SG11201400270PA (en) 2011-09-01 2012-08-31 Method for detecting nucleosomes containing nucleotides
JP2014527737A JP6322845B2 (ja) 2011-09-01 2012-08-31 ヌクレオチド含有ヌクレオソーム検出法
TR2019/04386T TR201904386T4 (tr) 2011-09-01 2012-08-31 Nükleotidleri içeren nükleozomların saptanmasına yönelik yöntem.
SG10201601153RA SG10201601153RA (en) 2011-09-01 2012-08-31 Method for detecting nucleosomes containing nucleotides
PT12756549T PT2751568T (pt) 2011-09-01 2012-08-31 Método para deteção de nucleossomos contendo nucleotídeos
CN201280053555.1A CN104067124B (zh) 2011-09-01 2012-08-31 用于检测含核苷酸的核小体的方法
MX2014002443A MX364410B (es) 2011-09-01 2012-08-31 Metodo para detectar nucleosomas que contienen nucleotidos.
EP12756549.7A EP2751568B1 (en) 2011-09-01 2012-08-31 Method for detecting nucleosomes containing nucleotides
HRP20190533TT HRP20190533T1 (hr) 2011-09-01 2012-08-31 Postupak za otkrivanje nukleosoma koji sadrže nukleotide
RU2017126701A RU2687483C2 (ru) 2011-09-01 2012-08-31 Способ детекции нуклеосом, содержащих нуклеотиды
HK15100175.0A HK1199760B (en) 2011-09-01 2012-08-31 Method for detecting nucleosomes containing nucleotides
HUE12756549A HUE043386T2 (hu) 2011-09-01 2012-08-31 Nukleotidokat tartalmazó nukleoszómák kimutatására szolgáló eljárás
RU2014112350/15A RU2014112350A (ru) 2011-09-01 2012-08-31 Способ детекции нуклеосом, содержащих нуклеотиды
CA2845993A CA2845993C (en) 2011-09-01 2012-08-31 Method for detecting nucleosomes containing nucleotides
KR1020147008108A KR102074528B1 (ko) 2011-09-01 2012-08-31 뉴클레오티드를 함유하는 뉴클레오솜의 검출 방법
PL12756549T PL2751568T3 (pl) 2011-09-01 2012-08-31 Metoda wykrywania nukleosomów zawierających nukleotydy
ES12756549T ES2717659T3 (es) 2011-09-01 2012-08-31 Procedimiento para la detección de nucleosomas que contienen nucleótidos
AU2012300641A AU2012300641B2 (en) 2011-09-01 2012-08-31 Method for detecting nucleosomes containing nucleotides
PCT/GB2012/052128 WO2013030577A1 (en) 2011-09-01 2012-08-31 Method for detecting nucleosomes containing nucleotides
BR112014005087-2A BR112014005087B1 (pt) 2011-09-01 2012-08-31 uso de uma base de dna associada com um nucleossoma livre de células como um biomarcador, métodos para detecção de uma base de dna, bem como métodos para detecção de um estado da doença em um animal ou ser humano, para avaliação da adaptação ao tratamento médico, e para monitoramento de um tratamento médico, e kit
EP18212025.3A EP3483608B1 (en) 2011-09-01 2012-08-31 Method for detecting nucleosomes containing nucleotides
US14/239,783 US10900064B2 (en) 2011-09-01 2012-08-31 Method for detecting nucleosomes containing nucleotides
ZA2014/01295A ZA201401295B (en) 2011-09-01 2014-02-20 Method for detecting nucleosomes containing nucleotides
US16/875,856 US20200347435A1 (en) 2011-09-01 2020-05-15 Method for detecting nucleosomes containing nucleotides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1115095.0A GB201115095D0 (en) 2011-09-01 2011-09-01 Method for detecting nucleosomes containing nucleotides

Publications (1)

Publication Number Publication Date
GB201115095D0 true GB201115095D0 (en) 2011-10-19

Family

ID=44882046

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1115095.0A Ceased GB201115095D0 (en) 2011-09-01 2011-09-01 Method for detecting nucleosomes containing nucleotides

Country Status (21)

Country Link
US (2) US10900064B2 (https=)
EP (2) EP2751568B1 (https=)
JP (1) JP6322845B2 (https=)
KR (1) KR102074528B1 (https=)
CN (1) CN104067124B (https=)
AU (1) AU2012300641B2 (https=)
BR (1) BR112014005087B1 (https=)
CA (1) CA2845993C (https=)
DK (1) DK2751568T3 (https=)
ES (1) ES2717659T3 (https=)
GB (1) GB201115095D0 (https=)
HR (1) HRP20190533T1 (https=)
HU (1) HUE043386T2 (https=)
MX (1) MX364410B (https=)
PL (1) PL2751568T3 (https=)
PT (1) PT2751568T (https=)
RU (2) RU2687483C2 (https=)
SG (2) SG11201400270PA (https=)
TR (1) TR201904386T4 (https=)
WO (1) WO2013030577A1 (https=)
ZA (1) ZA201401295B (https=)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10083273B2 (en) 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
CN102171565B (zh) 2008-08-04 2015-04-29 纳特拉公司 等位基因调用和倍性调用的方法
US20120185176A1 (en) 2009-09-30 2012-07-19 Natera, Inc. Methods for Non-Invasive Prenatal Ploidy Calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
EP2572003A4 (en) 2010-05-18 2016-01-13 Natera Inc METHOD FOR NONINVASIVE PRANATAL PLOIDIE ASSIGNMENT
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
WO2012088456A2 (en) 2010-12-22 2012-06-28 Natera, Inc. Methods for non-invasive prenatal paternity testing
AU2011358564B9 (en) 2011-02-09 2017-07-13 Natera, Inc Methods for non-invasive prenatal ploidy calling
GB201115095D0 (en) 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
EP2775304A1 (en) * 2013-03-07 2014-09-10 Universitätsspital Basel Methods for detecting inflammatory disorder
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US9499870B2 (en) * 2013-09-27 2016-11-22 Natera, Inc. Cell free DNA diagnostic testing standards
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
EP3957749A1 (en) 2014-04-21 2022-02-23 Natera, Inc. Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
WO2016049936A1 (en) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Biomarkers for rheumatoid arthritis and usage therof
AU2015340378B2 (en) 2014-10-29 2021-08-12 Belgian Volition Sprl Method for the enrichment of circulating tumor DNA
WO2016128383A1 (en) * 2015-02-10 2016-08-18 B.R.A.H.M.S Gmbh Free histone proteins as biomarkers
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
CN107922971A (zh) 2015-05-18 2018-04-17 凯锐思公司 用于富集核酸群体的组合物和方法
GB201511542D0 (en) * 2015-07-01 2015-08-12 Singapore Volition Pte Ltd Use of cell free nucleosomes as biomarkers
GB201511512D0 (en) * 2015-07-01 2015-08-12 Singapore Volition Pte Ltd Use of cell-free nucleosomes as biomarkers
GB201518674D0 (en) 2015-10-21 2015-12-02 Singapore Volition Pte Ltd Method for detecting nuleosomes containing histone modifications and variants
GB201518665D0 (en) 2015-10-21 2015-12-02 Singapore Volition Pte Ltd Method for enrichment of cell free nucleosomes
GB201604806D0 (en) * 2016-03-22 2016-05-04 Singapore Volition Pte Ltd Method of identifying a cancer of unknown origin
WO2017181202A2 (en) 2016-04-15 2017-10-19 Natera, Inc. Methods for lung cancer detection
CN107858416B (zh) * 2016-09-19 2021-05-28 深圳华大生命科学研究院 用于子宫内膜异位症检测的生物标志物组合及其应用
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
US10894976B2 (en) 2017-02-21 2021-01-19 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
CN107164508A (zh) * 2017-06-16 2017-09-15 上海易毕恩基因科技有限公司 用于检测肝癌的基因标志物及其用途
CN107385051A (zh) * 2017-08-04 2017-11-24 上海易毕恩生物技术有限公司 用于检测肝肿瘤良恶性的基因标志物、试剂盒及检测方法
JP2021506342A (ja) 2017-12-14 2021-02-22 ティーエーアイ ダイアグノスティックス インコーポレイテッドＴａｉ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． 移植のための移植片適合性の評価
US12398389B2 (en) 2018-02-15 2025-08-26 Natera, Inc. Methods for isolating nucleic acids with size selection
AU2019228625B2 (en) 2018-03-01 2024-11-07 Epicypher, Inc. Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
CA3090426A1 (en) 2018-04-14 2019-10-17 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
GB201818963D0 (en) 2018-11-21 2019-01-09 Belgian Volition Sprl Methof for the detection of prostate cancer
GB201818965D0 (en) 2018-11-21 2019-01-09 Belgian Volition Sprl Method for the detection of colorectal cancer
GB201906199D0 (en) 2019-05-02 2019-06-19 Belgian Volition Sprl Method for the detection of cancer
GB201906201D0 (en) 2019-05-02 2019-06-19 Belgian Voltion Sprl Method for the detection of protate cancer
EP3980559A1 (en) 2019-06-06 2022-04-13 Natera, Inc. Methods for detecting immune cell dna and monitoring immune system
JP2022545821A (ja) 2019-08-27 2022-10-31 ベルジアン ボリション エスアールエル 循環ヌクレオソームを単離する方法
GB201912251D0 (en) 2019-08-27 2019-10-09 Belgian Volition Sprl Method of isolating circulating nucleosomes
PL4070111T3 (pl) 2019-12-02 2025-02-03 Belgian Volition Srl Zastosowanie wolnych pozakomórkowych nukleosomsów jako biomarkerów
US20230204599A1 (en) 2020-03-20 2023-06-29 Belgian Volition SRL (BE/BE) Triaging method using cell free nucleosome levels
TW202238131A (zh) 2020-11-25 2022-10-01 比利時商比利時意志有限公司 測量無細胞核蛋白染色質片段之方法
TW202242145A (zh) 2020-12-29 2022-11-01 比利時商比利時意志有限公司 核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析
TW202242130A (zh) 2020-12-29 2022-11-01 比利時商比利時意志有限公司 循環轉錄因子分析
TW202242146A (zh) 2021-01-13 2022-11-01 比利時商比利時意志有限公司 肺癌的檢測方法
GB202108185D0 (en) 2021-06-08 2021-07-21 Belgian Volition Sprl Standardisation of nucleosome assays using biologically derived calibrants
GB202108452D0 (en) 2021-06-14 2021-07-28 Belgian Volition Sprl Triaging method using cell free nucleosome levels
EP4423501A1 (en) 2021-10-29 2024-09-04 Belgian Volition SRL Homogeneous immunoassay method
GB202117799D0 (en) 2021-12-09 2022-01-26 Belgian Volition Srl Method for the detection of blood cancer
WO2023170298A1 (en) 2022-03-11 2023-09-14 Belgian Volition Srl Differential diagnosis method
GB202205212D0 (en) 2022-04-08 2022-05-25 Belgian Volition Sprl Method for transplant organ health assessment
WO2024042210A1 (en) 2022-08-25 2024-02-29 Belgian Volition Srl Method for measuring cell free chromatin
EP4639165A1 (en) 2022-12-19 2025-10-29 Belgian Volition SRL Assessment of biological samples for nucleic acid analysis
GB202300607D0 (en) 2023-01-16 2023-03-01 Belgian Volition Srl Proteins and methods for isolating circulating nucleosomes
GB202303562D0 (en) 2023-03-10 2023-04-26 Belgian Volition Sprl Sample collection for liquid biopsy
WO2025061853A1 (en) 2023-09-19 2025-03-27 Belgian Volition Srl Lateral flow test device

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652901A1 (fr) 1989-10-11 1991-04-12 Pasteur Institut Complexes biologiques a base de nucleosomes, et leurs applications, notamment dans le domaine du diagnostic in vitro du lupus erythemateux dissemine (led).
US6630301B1 (en) * 1997-03-14 2003-10-07 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
ATE471150T1 (de) * 1996-03-26 2010-07-15 Kopreski Michael S Methoden aus plasma oder serum extrahierte extrazelluraere rna zur diagnoseüberwachung oder evaluation von krebs verwenden
EP1064549B1 (en) * 1998-03-18 2006-06-07 Roche Diagnostics GmbH Detection of apoptotic products
NL1014106C2 (nl) 2000-01-18 2001-07-20 Univ Amsterdam Werkwijze voor het detecteren van een pathologische afwijking bij een cel, een antistof en een assay kit.
ATE419392T1 (de) 2003-07-04 2009-01-15 Johnson & Johnson Res Pty Ltd Verfahren zum nachweis von alkyliertem cytosin in dna
GB0319376D0 (en) 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
WO2005040814A1 (en) 2003-10-14 2005-05-06 Cancer Research Technology Limited Methods and means of cancer detection by histone modification
ATE554184T1 (de) * 2004-12-16 2012-05-15 Harvard College Durch das nukleäre aminoxidase-homolog lsd1 vermittelte histondemethylierung
DE102005034628B4 (de) 2005-07-19 2007-08-23 Epigenomics Ag Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA
WO2007050706A2 (en) 2005-10-27 2007-05-03 University Of Missouri-Columbia Dna methylation biomarkers in lymphoid and hematopoietic malignancies
WO2007049286A1 (en) * 2005-10-27 2007-05-03 Tata Memorial Centre A system for ex-vivo separation of apoptotic chromatin particles from blood or plasma
WO2007076200A2 (en) 2005-11-28 2007-07-05 Medimmune, Inc. Antagonists of hmgb1 and/or rage and methods of use thereof
DE102006035600B3 (de) 2006-07-27 2007-11-08 Epigenomics Ag Verfahren zum Nachweis eines Methylierungsmusters
US20080131954A1 (en) * 2006-11-30 2008-06-05 Canon U.S. Life Sciences, Inc. Method of Separating Target DNA from Mixed DNA
WO2008130516A1 (en) * 2007-04-11 2008-10-30 Manel Esteller Epigenetic biomarkers for early detection, therapeutic effectiveness, and relapse monitoring of cancer
US7608402B2 (en) * 2008-01-10 2009-10-27 Weiwei Li DNA methylation specific signal amplification
WO2009115313A1 (en) 2008-03-19 2009-09-24 Oryzon Genomics, S.A. Method and composition for methylation analysis
HUE045093T2 (hu) 2008-11-21 2019-12-30 Kobenhavns Univ University Of Copenhagen Immunválasz kiváltása
BRPI1013546A2 (pt) 2009-04-14 2019-04-09 The Regente Of The University Of California usos de um inibidor da timidilato sintase e de uma terapia anticâncer
CN102612652B (zh) 2009-08-06 2016-05-04 康奈尔大学 用于分子分析的设备和方法
US20130183662A1 (en) 2010-04-22 2013-07-18 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Means and methods for identifying an increased risk of systemic lupus erythematosus (sle) patients for developing renal manifestations
WO2011150974A1 (en) 2010-06-03 2011-12-08 Porto Conte Ricerche S.R.L. Biomarkers for lung neuroendocrine tumors
FI20105715A0 (fi) 2010-06-18 2010-06-18 Helsingin Yliopisto Asetyloituun HMGB1:een sitoutuva polyklonaalinen vasta-aine
CN101955998A (zh) * 2010-07-20 2011-01-26 赵英仁 一种血浆游离dna水平检测肝细胞坏死程度的方法
GB201115095D0 (en) 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
GB201115098D0 (en) 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
CN104067125B (zh) * 2011-12-07 2017-12-26 比利时意志有限责任公司 用于检测核小体加合物的方法
HK1206055A1 (en) 2012-03-02 2015-12-31 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
GB201303575D0 (en) 2013-02-28 2013-04-10 Singapore Volition Pte Ltd Method for detecting histone modifications in nucleosomes

Also Published As

Publication number Publication date
PL2751568T3 (pl) 2019-09-30
DK2751568T3 (en) 2019-04-15
CA2845993C (en) 2020-10-13
RU2014112350A (ru) 2015-10-10
CA2845993A1 (en) 2013-03-07
AU2012300641A1 (en) 2014-03-06
KR20140078637A (ko) 2014-06-25
BR112014005087B1 (pt) 2020-12-22
SG10201601153RA (en) 2016-03-30
TR201904386T4 (tr) 2019-05-21
HRP20190533T1 (hr) 2019-06-28
JP2014531573A (ja) 2014-11-27
US20140363812A1 (en) 2014-12-11
BR112014005087A2 (pt) 2017-03-28
ES2717659T3 (es) 2019-06-24
MX364410B (es) 2019-04-25
HUE043386T2 (hu) 2019-08-28
RU2017126701A3 (https=) 2019-01-31
EP2751568A1 (en) 2014-07-09
SG11201400270PA (en) 2014-03-28
RU2017126701A (ru) 2019-01-31
KR102074528B1 (ko) 2020-02-06
MX2014002443A (es) 2014-10-13
AU2012300641B2 (en) 2017-09-28
EP3483608B1 (en) 2023-06-07
CN104067124B (zh) 2018-05-04
US20200347435A1 (en) 2020-11-05
RU2687483C2 (ru) 2019-05-14
PT2751568T (pt) 2019-04-16
EP2751568B1 (en) 2018-12-26
HK1199760A1 (en) 2015-07-17
EP3483608A1 (en) 2019-05-15
JP6322845B2 (ja) 2018-05-16
ZA201401295B (en) 2014-12-23
CN104067124A (zh) 2014-09-24
US10900064B2 (en) 2021-01-26
WO2013030577A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
ZA201401295B (en) Method for detecting nucleosomes containing nucleotides
GB201115099D0 (en) Method for detecting nucleosomes
ZA201401296B (en) Method for detecting nucleosomes containing histone variants
PL2772549T3 (pl) Sposób wykrywania zmienności genetycznej
IL230610A0 (en) Methods for detecting nucleotide change
IL234875B (en) A method for detecting a copy number change
IL237480B (en) Methods for identifying genetic changes
PL2583586T3 (pl) Urządzenie do wykrywania kolizji i odpowiedni sposób
EP2753236A4 (en) METHOD FOR DETECTING R-WAVES
ZA201307225B (en) Methods for genomic modification
PL2788767T3 (pl) Sposób wykrywania adduktów nukleosomowych
SG11201400635UA (en) Method for detecting target nucleic acid
EP2637017A4 (en) METHOD FOR MEASURING FILLING CAPACITY
ZA201405372B (en) Device and method for detecting deposits
SG11201402865XA (en) Method for detecting protein-protein interaction
GB2503856B (en) Methods for nucleic acid purification
EP2833140A4 (en) PROCESS FOR DETECTING BIOLOGICAL MATERIALX
EP2685257A4 (en) METHOD OF ANALYSIS
EP2740804A4 (en) PROCESS FOR NUCLEIC ACID ANALYSIS
EP2674739A4 (en) TORQUE SENSOR DEVICE
EP2743259A4 (en) PROCESS FOR CLEANING (S) -OXIRACETAM
EP2743258A4 (en) PROCESS FOR PURIFYING LEVO-OXIRACETAM
ZA201402728B (en) Carburizing sensing method
EP2891721A4 (en) METHOD FOR DETECTING TARGET NUCLEIC ACID
EP2843047A4 (en) NUCLEINSÄUREDETEKTIONSVERFAHREN

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)